Handbook Of Depression Second Edition

Bringing together the field's leading authorities, this acclaimed work is widely regarded as the standard reference on depression. The Handbook provides comprehensive coverage of the epidemiology, course, and outcome of depressive disorders; issues in assessment and diagnosis; psychological and biological risk factors; effective approaches to prevention and treatment; and the nature of depression in specific populations. Each chapter offers a definitive statement of current theories, methods, and research findings, while also identifying key questions that remain unanswered.

Depression is a common mood disorder that affects approximately 10% of the global population at some point in their lives and can cause serious psychological, physical, and cognitive distress. Additionally, patients with depression are at a greater risk for cardiovascular disease, stroke, functional impairment, disability and all-cause mortality. Aside from the impact on the individual, this condition presents a very real economic burden, as depression is the most predominant mental health problem among working-age patients and the leading cause of lost work productivity. Despite advances in screening and treating depression in recent decades, a vast majority of patients with depression do not actively seek treatment and, of those that do, only a quarter have been found to receive adequate and effective interventions. Handbook of Depression, Second Edition is a concise review of assessment tools, available and emerging pharmacological and non-pharmacological treatment options, and consensus management guidelines that center on enhancing the clinician-patient relationship and improving patient quality of life. Cowritten by expert US- and UK-based authors, this handbook has an innovative global focus that consolidates current knowledge in a convenient, pocket-sized guide that is ideal for every day reference in a clinical setting.

Features new to the second edition of this handbook include measurement scales used in research, breakthroughs in pharmacogenomics, epidemiology, genetics, psychophysiology and pharmacology, and enhanced therapeutic strategies and outcome measures for patient care and management.

Features new to the second edition of this handbook include measurement scales used in research, breakthroughs in pharmacogenomics, epidemiology, genetics, psychophysiology and pharmacology, and enhanced therapeutic strategies and outcome measures for patient care and management.

An authoritative reference on depression and mood disorders, this volume brings together the field's preeminent researchers. All aspects of unipolar and bipolar depression are addressed, from genetics, neurobiology, and social-contextual risk factors to the most effective approaches to assessment and clinical management. Contributors review what is known about depression in specific populations, exploring developmental issues across the lifespan as well as gender and cultural variables. Effective psychosocial and biological treatments are described in detail. Each chapter offers a definitive statement of current theories, methods, and findings, and identifies key questions that remain to be answered. New to This Edition *Incorporates cutting-edge research (including findings from international, multisite, integrative, and longitudinal studies), treatment advances, and changes to diagnostic criteria in DSM-5. *Chapters on comorbidity with anxiety disorders and emotional functioning in depression. *Expanded coverage of bipolar disorder, now the focus of three chapters (clinical features, risk and etiological factors, and treatment). *Many new authors and extensively revised chapters.

From leading experts in behavioral activation research and clinical practice, this volume presents an empirically tested approach for helping clients overcome depression by becoming active and engaged in their own lives. Behavioral activation is a stand-alone treatment whose principles can be integrated easily with other approaches that therapists already use. Guidelines are presented for identifying individualized treatment targets, monitoring and scheduling "antidepressant" activities -- experiences that are likely to be rewarding and pleasurable -- and decreasing avoidance and ruminative thinking. Rich clinical illustrations include an extended case example that runs throughout the book. Twenty-two reproducible forms, worksheets, and tables can be downloaded and printed in a convenient 8 1/2" x 11" size.